Published on 10 Mar 2022 on Benzinga
Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Arena Pharmaceuticals Inc. (NASDAQ: ARNA)Â traded today at a new 12-month high of $100.00. Approximately 748,000 shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares.
Potential upside of 0.2% exists for Arena Pharmaceuticals Inc., based on a current level of $99.99 and analysts’ average consensus price target of $100.19.